The risk of COVID-19 infection in patients with atopic dermatitis: A retrospective cohort study
Research output: Contribution to journal › Comment/debate › Research › peer-review
Original language | English |
---|---|
Journal | Journal of the American Academy of Dermatology |
Volume | 86 |
Issue number | 1 |
Pages (from-to) | 243-245 |
Number of pages | 3 |
ISSN | 0190-9622 |
DOIs |
|
Publication status | Published - Jan 2022 |
Bibliographical note
Funding Information:
Dr Wu is or has been an investigator, consultant, or speaker for AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Boehringer Ingelheim, Bristol–Myers Squibb, Dermavant, Dr Reddy's Laboratories, Eli Lilly, Galderma, Janssen, LEO Pharma, Mindera, Novartis, Regeneron, Sanofi Genzyme, Solius, Sun Pharmaceutical, UCB, Valeant Pharmaceuticals North America LLC, and Zerigo Health. Dr Egeberg has received research funding from Pfizer , Eli Lilly , Novartis , Bristol-Myers Squibb , AbbVie , Janssen Pharmaceuticals , the Danish National Psoriasis Foundation , the Simon Spies Foundation , and the Aage Bang's Foundation , and honoraria as consultant and/or speaker from AbbVie, Almirall, Leo Pharma, Galápagos NV, Sun Pharmaceuticals, Samsung Bioepis Co, Ltd, Pfizer, Eli Lilly, Novartis, Galderma, Dermavant, UCB, Mylan, Bristol–Myers Squibb, and Janssen Pharmaceuticals. Dr Thyssen has been an advisor, speaker, or investigator for AbbVie, LEO Pharma, Regeneron, Pfizer, Sanofi Genzyme, Almirall, and Eli Lilly. Dr Ge and Authors Martin, Liu, and Thatiparthi have no conflicts of interest to declare.
Funding Information:
Dr Wu is or has been an investigator, consultant, or speaker for AbbVie, Almirall, Amgen, Arcutis, Aristea Therapeutics, Boehringer Ingelheim, Bristol?Myers Squibb, Dermavant, Dr Reddy's Laboratories, Eli Lilly, Galderma, Janssen, LEO Pharma, Mindera, Novartis, Regeneron, Sanofi Genzyme, Solius, Sun Pharmaceutical, UCB, Valeant Pharmaceuticals North America LLC, and Zerigo Health. Dr Egeberg has received research funding from Pfizer, Eli Lilly, Novartis, Bristol-Myers Squibb, AbbVie, Janssen Pharmaceuticals, the Danish National Psoriasis Foundation, the Simon Spies Foundation, and the Aage Bang's Foundation, and honoraria as consultant and/or speaker from AbbVie, Almirall, Leo Pharma, Gal?pagos NV, Sun Pharmaceuticals, Samsung Bioepis Co, Ltd, Pfizer, Eli Lilly, Novartis, Galderma, Dermavant, UCB, Mylan, Bristol?Myers Squibb, and Janssen Pharmaceuticals. Dr Thyssen has been an advisor, speaker, or investigator for AbbVie, LEO Pharma, Regeneron, Pfizer, Sanofi Genzyme, Almirall, and Eli Lilly. Dr Ge and Authors Martin, Liu, and Thatiparthi have no conflicts of interest to declare.
- atopic dermatitis, COVID-19, dupilumab, epidemiology, infection
Research areas
ID: 314076774